Pfizer To Build R&D Center In Wuhan
This article was originally published in PharmAsia News
Executive Summary
Pfizer's R&D subsidiary in China has signed a cooperation agreement with Wuhan National Bioindustry Base (Biolake) to co-establish a research center in Wuhan